SSRP1 and hepatocellular carcinoma: Zheng et al. revealed that LINC01134 can interact with miR-4784 to inhibit the production of structure-specific recognition protein 1 (SSRP1) [11], consequently boosting hepatocellular carcinoma (HCC) development.